Novel multiplex technology for diagnostic characterization of rheumatoid arthritis

[1] Hueber W(2005)Antigen microarray profiling of autoantibodies in rheumatoid arthritis Arthritis Rheum 52 2645-2655

[2] Kidd BA(2007)Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines Ann Rheum Dis 66 712-719

[3] Tomooka BH(2007)The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice Ann Rheum Dis 66 1473-1478

[4] Lee BJ(2009)Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis Arthritis Res Ther 11 R76-1563

[5] Bruce B(2008)New automated multiplex assay for bone turnover markers in osteoporosis Clin Chem 54 1554-15872

[6] Fries JF(2009)A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis Proc Natl Acad Sci USA 106 15867-2329

[7] Sonderstrup G(2002)HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias Arthritis Rheum 46 2320-167

[8] Monach P(2005)The Arthritis, Rheumatism and Aging Medical Information System (ARAMIS): still young at 30 years Clin Exp Rheumatol 23 S163-324

[9] Drijfhout JW(1988)The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315-2806

[10] van Venrooij WJ(2006)Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks Arthritis Rheum 54 2793-5121

[1] Hueber W(2005)Antigen microarray profiling of autoantibodies in rheumatoid arthritis Arthritis Rheum 52 2645-2655

[2] Kidd BA(2007)Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines Ann Rheum Dis 66 712-719

[3] Tomooka BH(2007)The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice Ann Rheum Dis 66 1473-1478

[4] Lee BJ(2009)Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis Arthritis Res Ther 11 R76-1563

[5] Bruce B(2008)New automated multiplex assay for bone turnover markers in osteoporosis Clin Chem 54 1554-15872

[6] Fries JF(2009)A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis Proc Natl Acad Sci USA 106 15867-2329

[7] Sonderstrup G(2002)HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias Arthritis Rheum 46 2320-167

[8] Monach P(2005)The Arthritis, Rheumatism and Aging Medical Information System (ARAMIS): still young at 30 years Clin Exp Rheumatol 23 S163-324

[9] Drijfhout JW(1988)The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315-2806

[10] van Venrooij WJ(2006)Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks Arthritis Rheum 54 2793-5121